Publications by authors named "Panayiotis Argyriou"
Article Synopsis
- Antiphospholipid syndrome (APS) can occur either as a primary condition (PAPS) or as a secondary condition linked to autoimmune diseases like systemic lupus erythematosus (SLE), with recent studies indicating frequent brain involvement in these patients.
- The study involved 18 patients with SAPS and PAPS who underwent brain-heart MRI, revealing that while routine clinical tests showed no abnormalities, significant heart and brain issues, such as white matter hyperintensities and cardiac fibrosis, were present in many cases.
- The findings suggest that combined brain-heart MRI is a valuable diagnostic tool for identifying abnormalities in patients with cardiac symptoms related to APS, although further research is needed to integrate this imaging technique into standard medical practice.
Combined Brain-Heart Magnetic Resonance Imaging in Autoimmune Rheumatic Disease Patients with Cardiac Symptoms: Hypothesis Generating Insights from a Cross-sectional Study.
George Markousis-Mavrogenis Dimos D Mitsikostas Loukia Koutsogeorgopoulou Theodoros Dimitroulas Gikas Katsifis Panayiotis Argyriou
J Clin Med
February 2020
Background: Autoimmune rheumatic diseases (ARDs) may affect both the heart and the brain. However, little is known about the interaction between these organs in ARD patients. We asked whether brain lesions are more frequent in ARD patients with cardiac symptoms compared with non-ARD patients with cardiovascular disease (CVD).
View Article and Find Full Text PDFThe increasing use of cardiovascular magnetic resonance (CMR) is based on its capability to perform biventricular function assessment and tissue characterization without radiation and with high reproducibility. The use of late gadolinium enhancement (LGE) gave the potential of non-invasive biopsy for fibrosis quantification. However, LGE is unable to detect diffuse myocardial disease.
View Article and Find Full Text PDF